INS and type 2 diabetes mellitus: The rapid deterioration of β-cell function observed in early-onset phenotype usually leads to necessitation of insulin therapy at earlier stages in those patients compared to the later-onset T2DM (in >50% of patients by 2–5 years after diagnosis) [2, 60].